Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

NCT: NCT03706430 · TERMINATED

NCT IDNCT03706430
StatusTERMINATED
Start Date2018-09-24
Completion2021-10-20
SponsorMasimo Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑